Preclinical evaluation of JQ1 in esophageal squamous cell carcinoma: growth and migration suppression with BRD4-associated DNA damage and apoptotic signaling.

Pu C, Liu J, Fan H, Hu H, Chen T, Tang J

Open source

DOI
10.3389/fphar.2026.1829810
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1829810,
  title = {Preclinical evaluation of JQ1 in esophageal squamous cell carcinoma: growth and migration suppression with BRD4-associated DNA damage and apoptotic signaling.},
  author = {Pu C and Liu J and Fan H and Hu H and Chen T and Tang J},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1829810},
  url = {https://doi.org/10.3389/fphar.2026.1829810}
}

RIS

TY  - JOUR
TI  - Preclinical evaluation of JQ1 in esophageal squamous cell carcinoma: growth and migration suppression with BRD4-associated DNA damage and apoptotic signaling.
AU  - Pu C
AU  - Liu J
AU  - Fan H
AU  - Hu H
AU  - Chen T
AU  - Tang J
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1829810
UR  - https://doi.org/10.3389/fphar.2026.1829810
ER  - 

APA

C, P., J, L., H, F., H, H., T, C., & J, T. (2026). Preclinical evaluation of JQ1 in esophageal squamous cell carcinoma: growth and migration suppression with BRD4-associated DNA damage and apoptotic signaling.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1829810

Source records